 Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration USFDA for Fingolimod Capsules, 0.5 mg, the generic version of Gilenya capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation, the drug major said in a filing to BSE. 